The Nucleic Acid Amplification Testing (NAAT) Market is expanding as hospitals, diagnostic laboratories, and public health agencies shift toward rapid, high-sensitivity molecular diagnostics for early disease detection and targeted treatment. Growth is supported by rising infectious disease prevalence, expansion of point-of-care (POC) testing platforms, oncology biomarker screening, and...